These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 21703676
21. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Wells PS, Forgie MA, Simms M, Greene A, Touchie D, Lewis G, Anderson J, Rodger MA. Arch Intern Med; 2003 Apr 28; 163(8):917-20. PubMed ID: 12719200 [Abstract] [Full Text] [Related]
22. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study. Santamaría A, Juárez S, Reche A, Gómez-Outes A, Martínez-González J, Fontcuberta J, ESFERA Investigators. Int J Clin Pract; 2006 May 28; 60(5):518-25. PubMed ID: 16700847 [Abstract] [Full Text] [Related]
23. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration. Wong YM, Quek YN, Tay JC, Chadachan V, Lee HK. J Clin Pharm Ther; 2011 Oct 28; 36(5):585-91. PubMed ID: 21070296 [Abstract] [Full Text] [Related]
28. Value of Cardiac Troponin and sPESI in Treatment of Pulmonary Thromboembolism at Outpatient Setting. Ozsu S, Bektas H, Abul Y, Ozlu T, Örem A. Lung; 2015 Aug 26; 193(4):559-65. PubMed ID: 25840529 [Abstract] [Full Text] [Related]
29. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. Caprini JA, Tapson VF, Hyers TM, Waldo AL, Wittkowsky AK, Friedman R, Colgan KJ, Shillington AC, NABOR Steering Committee. J Vasc Surg; 2005 Oct 26; 42(4):726-33. PubMed ID: 16242561 [Abstract] [Full Text] [Related]
30. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial. Klok FA, Toenges G, Mavromanoli AC, Barco S, Ageno W, Bouvaist H, Brodmann M, Cuccia C, Couturaud F, Dellas C, Dimopoulos K, Duerschmied D, Empen K, Faggiano P, Ferrari E, Galiè N, Galvani M, Ghuysen A, Giannakoulas G, Huisman MV, Jiménez D, Kozak M, Lang IM, Lankeit M, Meneveau N, Münzel T, Palazzini M, Petris AO, Piovaccari G, Salvi A, Schellong S, Schmidt KH, Verschuren F, Schmidtmann I, Meyer G, Konstantinides SV, PEITHO-2 investigators. Lancet Haematol; 2021 Sep 26; 8(9):e627-e636. PubMed ID: 34363769 [Abstract] [Full Text] [Related]
31. Inpatient enoxaparin and outpatient aspirin chemoprophylaxis regimen after primary hip and knee arthroplasty: a preliminary study. Hamilton SC, Whang WW, Anderson BJ, Bradbury TL, Erens GA, Roberson JR. J Arthroplasty; 2012 Oct 26; 27(9):1594-8. PubMed ID: 22480528 [Abstract] [Full Text] [Related]
34. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. N Engl J Med; 1999 Sep 09; 341(11):793-800. PubMed ID: 10477777 [Abstract] [Full Text] [Related]
35. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S, RECORD2 Investigators. Lancet; 2008 Jul 05; 372(9632):31-9. PubMed ID: 18582928 [Abstract] [Full Text] [Related]
36. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study. Marlovits S, Striessnig G, Schuster R, Stocker R, Luxl M, Trattnig S, Vécsei V. Arthroscopy; 2007 Jul 05; 23(7):696-702. PubMed ID: 17637403 [Abstract] [Full Text] [Related]
37. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH. N Engl J Med; 1996 Mar 14; 334(11):682-7. PubMed ID: 8594426 [Abstract] [Full Text] [Related]
38. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Zondag W, den Exter PL, Crobach MJ, Dolsma A, Donker ML, Eijsvogel M, Faber LM, Hofstee HM, Kaasjager KA, Kruip MJ, Labots G, Melissant CF, Sikkens MS, Huisman MV, Hestia Study Investigators. Thromb Haemost; 2013 Jan 14; 109(1):47-52. PubMed ID: 23138355 [Abstract] [Full Text] [Related]
39. Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy. Maestre A, Trujillo-Santos J, Riera-Mestre A, Jiménez D, Di Micco P, Bascuñana J, Vela JR, Peris L, Malfante PC, Monreal M, RIETE Investigators. Ann Am Thorac Soc; 2015 Aug 14; 12(8):1122-9. PubMed ID: 26114586 [Abstract] [Full Text] [Related]
40. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations. Prandoni P. Thromb Res; 2014 Aug 14; 134(2):227-33. PubMed ID: 24875390 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]